A Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 in Patients With Gout or Hyperuricemia

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 27, 2020

Primary Completion Date

October 26, 2021

Study Completion Date

October 26, 2021

Conditions

GoutHyperuricemia

Interventions

DRUG

ABP-671

ABP-671 Tablet

DRUG

Placebo

Trial Locations (5)

Paratus - Canberra Clinic, Canberra

Paratus - Central Coast Clinic, Kanwal

Peninsula Private Hospital, Kippa-Ring

Emeritus Research - Melbourne, Melbourne

Paratus - Western Sydney Clinic, Sydney